| PERIOD ENDING | 28-Mar-09 | 29-Mar-08 | 31-Mar-07 | | Total Revenue | 174,642 | 181,885 | 182,304 | | Cost of Revenue | 77,458 | 78,652 | 73,290 | | | Gross Profit | 97,184 | 103,233 | 109,014 | | | Operating Expenses | | Research Development | 44,315 | 48,484 | 43,961 | | Selling General and Administrative | 45,304 | 53,554 | 51,755 | | Non Recurring | 4,349 | 15,960 | 7,321 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 3,216 | (14,765) | 5,977 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,941 | 11,964 | 13,516 | | Earnings Before Interest And Taxes | 6,157 | (2,801) | 19,493 | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | 6,157 | (2,801) | 19,493 | | Income Tax Expense | 2,682 | 3,045 | (8,402) | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 3,475 | (5,846) | 27,895 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 3,475 | (5,846) | 27,895 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $3,475 | ($5,846) | $27,895 |
|
1.52% Nasdaq 0.00%
Income Statement
